Influenza

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
NCT04074928 | PHASE 3 | INTERVENTIONAL

This phase 3 clinical study is a randomized, observer-blind, comparator-controlled, multicenter study of QIVc versus a US-licensed comparator QIV in children 6 months through 47 months of age. The purpose of this study is to demonstrate that vaccination with QIVc elicits an immune response that is noninferior to that of a US-licensed comparator QIV containing the same virus strains, in children 6 months through 47 months of age.

Trial Information
47 Sites
2414 Participants
Recruiting
6 Months to 47 Months

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
CCR Research
Mobile,Alabama,United States,36608
Southland Clnical Research Center
Anaheim,California,United States,92804
Premier Health Research Center
Downey,California,United States,90240
Orange County Research Institute
Ontario,California,United States,91763
Center for Clinical Trials
Paramount,California,United States,90723
Benchmark Research
Sacramento,California,United States,95864
California Research Foundation
San Diego,California,United States,92123
Acevedo Clincal Research Associates
Miami,Florida,United States,33142
Sunshine Research Center
Opa-locka,Florida,United States,33054
Tekton Research
Chamblee,Georgia,United States,30341
Advanced Clinical Research
Meridian,Idaho,United States,83642
Heartland Research Associates
El Dorado,Kansas,United States,67042
Heartland Research Associates
Newton,Kansas,United States,67114
Heartland Research Associates
Wichita,Kansas,United States,67205
Heartland Research Associates
Wichita,Kansas,United States,67207
Kentucky Pediatric Adult Research
Bardstown,Kentucky,United States,40004
Bluegrass Clinical Research Inc.
Louisville,Kentucky,United States,40291
Meridian Clinical Research
Baton Rouge,Louisiana,United States,70806
ACC Pediatric Research
Haughton,Louisiana,United States,71037
Benchmark Research
Metairie,Louisiana,United States,70006
Med Pharmics
Metairie,Louisiana,United States,70006
MedPharmics
Gulfport,Mississippi,United States,39503
Office of Craig A. Spiegel
Bridgeton,Missouri,United States,63044
Center for Pharmaceutical Research
Kansas City,Missouri,United States,64114
Meridian Clinical Research
Norfolk,Nebraska,United States,68701
Meridian Clinical Research
Omaha,Nebraska,United States,68116
Med Pharmics
Albuquerque,New Mexico,United States,87102
Regional Clinical Research
Binghamton,New York,United States,13901
Dayton Clinical
Dayton,Ohio,United States,45406
PriMed Clinical Research
Dayton,Ohio,United States,45419
Meridian Clinical Research
Dakota Dunes,South Dakota,United States,57049
Clinical Research Associates
Nashville,Tennessee,United States,37203
Benchmark Research
Austin,Texas,United States,78705
Ventavia Research Group
Fort Worth,Texas,United States,76104
Universtiy of North Texas Health Science Center
Fort Worth,Texas,United States,76107
Benchmark Research
Fort Worth,Texas,United States,76135
Ventavia Research Group
Houston,Texas,United States,77008
West Houston Clinical Research
Houston,Texas,United States,77055
Ventavia Research Group
Keller,Texas,United States,76248
Benchmark Research
San Angelo,Texas,United States,76904
Tekton Research
San Antonio,Texas,United States,78240
Pediatric Healthcare of NW Houston
Tomball,Texas,United States,77375
Tanner Clinic
Layton,Utah,United States,84041
JBR Clinical Research Group
Salt Lake City,Utah,United States,84107
J. Lewis ResearchFoothill Family Clinic South
Salt Lake City,Utah,United States,84121
Advanced Clinical Research
West Jordan,Utah,United States,84088
Pediatric Research of Charlottesville
Charlottesville,Virginia,United States,22902

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov